All updated as on -
The market for flow cytometry was estimated to be worth $4.18 billion in 2022, and it is anticipated to increase to $10.22 billion by 2030, with a CAGR of 9.3% between 2023 and 2030.
With regard to describing and distinguishing various cell types in a heterogeneous cell population, measuring cell size and volume, and determining the purity of isolated subpopulations, flow cytometry is a commonly utilized technique. It enables the simultaneous examination of multiple parameters for a single cell. It is used to quantify the amount of fluorescence that fluorescently-labeled antibodies emit when they identify proteins and ligands that bind to particular compounds found in cells, such as DNA and propidium iodide. Following the staining step, cells are placed in tubes or microtiter plates and incubated with unlabeled or fluorescently-labeled antibodies before being analyzed on a flow cytometer.
The use of flow cytometry has increased as a result of the COVID-19 epidemic. Due to its improved accuracy and throughput capacity, the approach presents a possible substitute for COVID-19 testing since it can get around the drawbacks of existing PCR- or antibody-based testing solutions. Consequently, the sector has expanded as a result of the adoption of flow cytometry-based techniques for COVID-19 diagnoses and disease surveillance. The introduction of new products in this field also shows that the pandemic has sparked advances in the field of flow cytometry.
The test makes use of flow cytometry to provide crucial details about a patient's reaction to COVID-19 antigens and to assist in making wise treatment decisions. It is projected that the introduction of such innovations would foster industry growth in the near future. Another reason influencing the adoption of flow cytometry techniques is the increased prevalence of infectious diseases worldwide. Effective immunophenotyping & cell isolation alternatives are crucial for the mitigation of these diseases, which each year cause over 4.5 million fatalities. Pathogenic microorganisms are easily detectable from environmental samples using this approach, which can provide a viable immunophenotyping option.
The development and commercialization of technologically cutting-edge flow cytometry solutions that offer streamlined workflows, simplicity of use, and quicker turnaround times is becoming the focus of major businesses operating in the global market. As a result, new, cost-effective, portable, and user-friendly flow cytometry devices are created. Especially in established markets where the adoption rate of technologically advanced items is high, such new products operate as key driving factors during the forecast period.
Many flow cytometry instruments are needed at once by the majority of end users, including clinical laboratories, significant research centers, and pharmaceutical corporations to conduct numerous research studies. The expense for purchasing and maintaining such gadgets could significantly increase as a result of this. Additionally, the overall increase in the total cost of ownership of these instruments is brought on by the maintenance charges as well as a number of other indirect expenses. The best use of flow cytometry instruments in clinical and research applications is hampered by increased product installation costs and expenses, particularly in developing countries. Cost increases will eventually stifle the market since flow cytometry-based cell sorters are more expensive than cell analyzers.
Both academic and medical research and diagnosis use flow cytometry technologies to examine and quantify numerous cell properties. In the clinical setting, it is employed in the evaluation of organ transplants as well as the diagnosis of cancer, blood disorders (including leukemia and lymphoma), and HIV illnesses. The collection of samples is a significant difficulty for proper analysis, but with the development of robotics in flow cytometry, it is now achievable. Clinical and healthcare applications, genomics, proteomics, marine biology, microbiology & environmental sciences, and molecular cytogenetics all heavily utilize flow cytometry technology. It is used in multiplex arrays in the field of genomics to identify genetic abnormalities and genotype individuals. mRNA typing, microorganism identification, and subtyping are other uses in the realm of genomics.
An increase in R&D spending by life sciences organizations in recent years has been a major factor driving the flow cytometry market. The Savills India Report estimates that in August 2021, India received $448 million in venture capital funding for the bio sciences sector. The annual average over the previous five years was practically tripled. It was attributed to possible opportunities in the development of pharmaceuticals and medical devices.
The global flow cytometry market report details market share, recent developments, and product pipeline analysis. It also examines the impact of domestic and localized market players and examines opportunities in terms of new revenue pockets, regulatory changes, product approvals, strategic choices, product launches, geographic expansions, and technological advancements in the market. Contact us to get an analyst brief in order to comprehend the study and the market environment. To help you reach your desired goal, our team will assist you in developing a revenue impact solution. The main factors that fueled the market's demand over the projection period were the viability and commercial expansion of retail units in developing nations across various regions, as well as partnerships with suppliers for the secure distribution of machine and pharmaceutical items.
Report Coverage
Global Flow Cytometry research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Flow Cytometry report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Flow Cytometry competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Flow Cytometry market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Flow Cytometry market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Flow Cytometry market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd.(U.K.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (a subsidiary of IQVIA) (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories(U.S.), Bay bioscience Co., Ltd. (Japan), Cell Signaling Technology, Inc. (U.S.), CytoBuoy b.v. (Europe), ORFLO Technologies (U.S.), IKEDA SCIENTIFIC Co., Ltd. (Japan), BioLegend, Inc. (U.S.), Coherent Corp. (U.S.), Union Biometrica, Inc. (U.S.), Cytonome/ST, LLC (U.S.), Stratedigm, Inc (U.S.), NanoCellect Biomedical(U.S.), BennuBio Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), On-chip Biotechnologies Co., Ltd. Corporation (Japan), Enzo Biochem Inc. (U.S.) among others
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Flow Cytometry market based on the below-mentioned segments:
Global Flow Cytometry Market, By Component
Instruments
Reagents and consumables
Software
Services
Global Flow Cytometry market, By Application
Academic and clinical applications
Diagnostic applications
Global Flow Cytometry Market, By End User
Hospitals
Medical schools and clinical testing labs
Commercial organizations
Academic institutions
Others
Global Flow Cytometry market, Regional Analysis
With regard to describing and distinguishing various cell types in a heterogeneous cell population, measuring cell size and volume, and determining the purity of isolated subpopulations, flow cytometry is a commonly utilized technique. It enables the simultaneous examination of multiple parameters for a single cell. It is used to quantify the amount of fluorescence that fluorescently-labeled antibodies emit when they identify proteins and ligands that bind to particular compounds found in cells, such as DNA and propidium iodide. Following the staining step, cells are placed in tubes or microtiter plates and incubated with unlabeled or fluorescently-labeled antibodies before being analyzed on a flow cytometer.
The use of flow cytometry has increased as a result of the COVID-19 epidemic. Due to its improved accuracy and throughput capacity, the approach presents a possible substitute for COVID-19 testing since it can get around the drawbacks of existing PCR- or antibody-based testing solutions. Consequently, the sector has expanded as a result of the adoption of flow cytometry-based techniques for COVID-19 diagnoses and disease surveillance. The introduction of new products in this field also shows that the pandemic has sparked advances in the field of flow cytometry.
The test makes use of flow cytometry to provide crucial details about a patient's reaction to COVID-19 antigens and to assist in making wise treatment decisions. It is projected that the introduction of such innovations would foster industry growth in the near future. Another reason influencing the adoption of flow cytometry techniques is the increased prevalence of infectious diseases worldwide. Effective immunophenotyping & cell isolation alternatives are crucial for the mitigation of these diseases, which each year cause over 4.5 million fatalities. Pathogenic microorganisms are easily detectable from environmental samples using this approach, which can provide a viable immunophenotyping option.
The development and commercialization of technologically cutting-edge flow cytometry solutions that offer streamlined workflows, simplicity of use, and quicker turnaround times is becoming the focus of major businesses operating in the global market. As a result, new, cost-effective, portable, and user-friendly flow cytometry devices are created. Especially in established markets where the adoption rate of technologically advanced items is high, such new products operate as key driving factors during the forecast period.
Many flow cytometry instruments are needed at once by the majority of end users, including clinical laboratories, significant research centers, and pharmaceutical corporations to conduct numerous research studies. The expense for purchasing and maintaining such gadgets could significantly increase as a result of this. Additionally, the overall increase in the total cost of ownership of these instruments is brought on by the maintenance charges as well as a number of other indirect expenses. The best use of flow cytometry instruments in clinical and research applications is hampered by increased product installation costs and expenses, particularly in developing countries. Cost increases will eventually stifle the market since flow cytometry-based cell sorters are more expensive than cell analyzers.
Both academic and medical research and diagnosis use flow cytometry technologies to examine and quantify numerous cell properties. In the clinical setting, it is employed in the evaluation of organ transplants as well as the diagnosis of cancer, blood disorders (including leukemia and lymphoma), and HIV illnesses. The collection of samples is a significant difficulty for proper analysis, but with the development of robotics in flow cytometry, it is now achievable. Clinical and healthcare applications, genomics, proteomics, marine biology, microbiology & environmental sciences, and molecular cytogenetics all heavily utilize flow cytometry technology. It is used in multiplex arrays in the field of genomics to identify genetic abnormalities and genotype individuals. mRNA typing, microorganism identification, and subtyping are other uses in the realm of genomics.
An increase in R&D spending by life sciences organizations in recent years has been a major factor driving the flow cytometry market. The Savills India Report estimates that in August 2021, India received $448 million in venture capital funding for the bio sciences sector. The annual average over the previous five years was practically tripled. It was attributed to possible opportunities in the development of pharmaceuticals and medical devices.
The global flow cytometry market report details market share, recent developments, and product pipeline analysis. It also examines the impact of domestic and localized market players and examines opportunities in terms of new revenue pockets, regulatory changes, product approvals, strategic choices, product launches, geographic expansions, and technological advancements in the market. Contact us to get an analyst brief in order to comprehend the study and the market environment. To help you reach your desired goal, our team will assist you in developing a revenue impact solution. The main factors that fueled the market's demand over the projection period were the viability and commercial expansion of retail units in developing nations across various regions, as well as partnerships with suppliers for the secure distribution of machine and pharmaceutical items.
Report Coverage
Global Flow Cytometry research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Flow Cytometry report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Flow Cytometry competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Flow Cytometry market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd.(U.K.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (a subsidiary of IQVIA) (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories(U.S.), Bay bioscience Co., Ltd. (Japan), Cell Signaling Technology, Inc. (U.S.), CytoBuoy b.v. (Europe), ORFLO Technologies (U.S.), IKEDA SCIENTIFIC Co., Ltd. (Japan), BioLegend, Inc. (U.S.), Coherent Corp. (U.S.), Union Biometrica, Inc. (U.S.), Cytonome/ST, LLC (U.S.), Stratedigm, Inc (U.S.), NanoCellect Biomedical(U.S.), BennuBio Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), On-chip Biotechnologies Co., Ltd. Corporation (Japan), Enzo Biochem Inc. (U.S.) among others |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Flow Cytometry Market from 2021 to 2030.
- Market Forecast for Flow Cytometry Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Flow Cytometry competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Flow Cytometry
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Flow Cytometry market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Flow Cytometry market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd.(U.K.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (a subsidiary of IQVIA) (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories(U.S.), Bay bioscience Co., Ltd. (Japan), Cell Signaling Technology, Inc. (U.S.), CytoBuoy b.v. (Europe), ORFLO Technologies (U.S.), IKEDA SCIENTIFIC Co., Ltd. (Japan), BioLegend, Inc. (U.S.), Coherent Corp. (U.S.), Union Biometrica, Inc. (U.S.), Cytonome/ST, LLC (U.S.), Stratedigm, Inc (U.S.), NanoCellect Biomedical(U.S.), BennuBio Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), On-chip Biotechnologies Co., Ltd. Corporation (Japan), Enzo Biochem Inc. (U.S.) among others
Primary Target Market
- Market Players of Flow Cytometry
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Flow Cytometry market based on the below-mentioned segments:
Global Flow Cytometry Market, By Component
Instruments
Reagents and consumables
Software
Services
Global Flow Cytometry market, By Application
Academic and clinical applications
Diagnostic applications
Global Flow Cytometry Market, By End User
Hospitals
Medical schools and clinical testing labs
Commercial organizations
Academic institutions
Others
Global Flow Cytometry market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive flow cytometry market market research and competitor analysis for your business to help you develop more profound insights into the flow cytometry market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the flow cytometry market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.